Couverture de Investors' Chronicle

Investors' Chronicle

Investors' Chronicle

De : Investors' Chronicle
Écouter gratuitement

À propos de cette écoute

Looking to stay informed in the world of investing? Investors' Chronicle dives into the key trends shaping today’s markets and unpacks what they mean for your investments. Featuring exclusive interviews with professional investors - whether fund managers or leading financial experts - our mission is to help you make smarter investment decisions.


Investors' Chronicle is a service by the Financial Times.

Hosted on Acast. See acast.com/privacy for more information.

7c8cb0a0-0e46-11f0-af5a-659c181aa6b8
Economie Finances privées Politique et gouvernement
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !
    Épisodes
    • PensionBee, Applied Nutrition & leasehold issues: The Companies and Markets Show
      Aug 22 2025

      We begin with Mark Robinson talking PensionBee’s (PBEE) results. The company’s marketing push in the US was a key theme in its latest update, a region where it sees a big opportunity. Mark and Dan discuss how both its US and UK arms are faring, as well as its valuation case.


      Next up, Holly McKechnie discusses our latest Big Read on beating the trap of leasehold properties. Holly and Dan unpack everything from how to spot issues when renting or buying a leasehold to the impact Labour’s reforms will have.


      Last up, Valeria Martinez covers whey-based protein products producer Applied Nutrition (APN). Its second-half results showed good performance thanks to well-received product launches. Valeria explains why momentum is on the company’s side.


      Timestamps

      1:25 PensionBee

      18:00 Leaseholds

      34:48 Applied Nutrition



      Hosted on Acast. See acast.com/privacy for more information.

      Afficher plus Afficher moins
      45 min
    • Spotting undervalued shares, Savills & weight-loss drugs: The Companies and Markets Show
      Aug 15 2025

      We begin with Hugh Moorhead and recent results from Savills (SVS), which were in line with expectations. Hugh and Dan unpack what divisions brought in the highest profits, a breakdown of a handful of global performances, and what the business’s valuation appears to be.


      Next up James Norrington joins to unpack our latest Big Read on sum-of-the-parts valuations. James explains the thinking behind the piece, how it can help find stocks trading at less than their worth, and how to tell if a company is focusing on the right part of a business.


      Lastly, Julian Hofmann covers Novo Nordisk (DK:NOVO.B), which saw shares rise after Eli Lilly’s (US:LLY) oral weight-loss pill underwhelmed regulators. Competition is still fierce in the sector, but a new Novo CEO could give the company the boost it needs.

      Read more on these topics

      How to spot undervalued shares

      Deep Dives


      Timestamps

      1:16 Savills

      13:41 Spotting undervalued shares

      26:33 Weight loss drugs

      Hosted on Acast. See acast.com/privacy for more information.

      Afficher plus Afficher moins
      39 min
    • Jupiter, retirement strategies and Science Group
      Aug 1 2025

      This week on the show, Mark Robinson and Julian Hofmann discuss interim figures from asset manager Jupiter, and ask whether the company – and the wider sector – is truly on the road to recovery.


      Our big read of the week looks at six different ways of pension planning. Personal finance editor Val Cipriani analyses the all-important topic of how to make your money last in your retirement.


      Finally Valeria Martinez looks at recent results from consultancy turned activist investor Science Group, which is sitting on excess cash made from its stake in rival Ricardo earlier this year.


      Listen to more podcasts from Investors’ Chronicle on Apple, Spotify and YouTube


      Timestamps

      1:38 Jupiter

      13:35 Retirement Strategies

      24:44 Science Group


      Midroll 24:43


      Find out more about these topics:

      One-third drop in Jupiter’s earnings clouds recovery hopes

      How to find your ‘retirement profile’ – and how to invest for it

      Science Group cashes in on Ricardo activist campaign


      Hosted on Acast. See acast.com/privacy for more information.

      Afficher plus Afficher moins
      34 min
    Aucun commentaire pour le moment